Arcutis Biotherapeutics
Price & Volume
Stats
See more52W Range | $6.99-$16.20 |
Market Cap | $1.5B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $138.7M |
Revenue Growth (YoY) | 17.4% |
Gross Profit (12 Mos) | $124.2M |
Diluted EPS | -$1.67 |
News
See moreYahoo Finance • 5 days ago
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
Yahoo Finance • 18 days ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
UPDATE 1-US FDA approves Arcutis' drug to treat chronic skin disease
About
CEO | Mr. Todd Franklin Watanabe M.A. |
Address | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 296 |
